(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
-1.77% $ 1.110
Live Chart Being Loaded With Signals
Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary...
Stats | |
---|---|
Volumen de hoy | 296 322 |
Volumen promedio | 594 359 |
Capitalización de mercado | 110.18M |
EPS | $-0.280 ( 2021-11-15 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.694 |
ATR14 | $0.0990 (8.92%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-01-24 | Klein Christopher | Sell | 9 605 | Ordinary Shares |
2020-05-20 | Cowan Gregory L | Buy | 38 716 | Ordinary Shares |
2020-05-21 | Cowan Gregory L | Sell | 11 112 | Ordinary Shares |
2020-01-28 | Schaub James | Sell | 9 197 | Ordinary Shares |
2019-01-24 | Weiss Fred G | Buy | 34 403 | Ordinary Shares |
INSIDER POWER |
---|
0.00 |
Last 6 transactions |
Buy: 177 968 | Sell: 29 914 |
Volumen Correlación
Osmotica Pharmaceuticals Correlación
10 Correlaciones Más Negativas | |
---|---|
CFBK | -0.899 |
DOX | -0.871 |
ARDX | -0.87 |
GLBZ | -0.865 |
CERC | -0.853 |
FATP | -0.852 |
IMTX | -0.852 |
PBPB | -0.848 |
CRVS | -0.845 |
ECOR | -0.843 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Osmotica Pharmaceuticals Correlación - Moneda/Commodity
Osmotica Pharmaceuticals Finanzas
Annual | 2022 |
Ingresos: | $49.72M |
Beneficio Bruto: | $40.27M (80.98 %) |
EPS: | $-0.580 |
FY | 2022 |
Ingresos: | $49.72M |
Beneficio Bruto: | $40.27M (80.98 %) |
EPS: | $-0.580 |
FY | 2020 |
Ingresos: | $177.88M |
Beneficio Bruto: | $103.40M (58.13 %) |
EPS: | $-1.520 |
FY | 2019 |
Ingresos: | $240.03M |
Beneficio Bruto: | $128.40M (53.49 %) |
EPS: | $-5.17 |
Financial Reports:
No articles found.
Osmotica Pharmaceuticals
Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary. The company's promoted products include M-72, a methylphenidate hydrochloride extended-release tablet to treat attention deficit hyperactivity disorder (ADHD); Osmolex ER, an amantadine extended-release tablet for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions in adults; Arbaclofen extended-release tablets which is in phase III clinical trial for the treatment of multiple sclerosis spasticity; Upneeq, an oxymetazoline hydrochloride ophthalmic solution for the treatment of Blepharoptosis; and OS870 which is in Phase I clinical trial for the treatment of neurodegenerative disorders. It also provides women's health products, including Divigel for menopause; and OB Complete, a dietary supplement for prenatal, pregnancy, and postnatal periods. In addition, the company's non-promoted products comprise methylphenidate ER tablets for ADHD; venlafaxine ER tablets to treat major depressive disorders and social anxiety disorders; hydromorphone ER for treating pain; nifedipine ER for hypertension; sodium benzoate/sodium phenylacetate for the treatment of hyperammonemia; oxybutynin ER for overactive bladder; prescription prenatal vitamins for treating nutritional requirements during pregnancy; Lorzone, an immediate-release form of chlorzoxazone indicated for the treatment of acute musculoskeletal pain in conjunction with rest and physical therapy; ConZip, a tramadol hydrochloride for the management of pain; and nitrofurantoin for the treatment of urinary tract infections, as well as Osmodex and other abbreviated new drug applications. Osmotica Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico